For research use only. Not for therapeutic Use.
Diphenhydramine Salicylate(CAT: I026260) is a compound combining the antihistamine properties of diphenhydramine with the anti-inflammatory effects of salicylate. It is primarily used in pharmacological research to study its dual action on histamine-mediated allergic responses and inflammatory pathways. By blocking H1 histamine receptors, it reduces symptoms such as itching and swelling, while the salicylate component contributes to pain relief and anti-inflammatory effects. Diphenhydramine Salicylate is ideal for investigating conditions such as allergies, dermatological inflammation, and related disorders. Its high purity and stability make it suitable for in vitro and in vivo studies, supporting research into combination therapies for allergic and inflammatory conditions.
Catalog Number | I026260 |
CAS Number | 7491-10-3 |
Synonyms | Diphenhydramine salicylate; Ibelomin; Salibena; Zeresmin |
Molecular Formula | C24H27NO4 |
Purity | 98% |
Solubility | To be determined |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 2-benzhydryloxy-N,N-dimethylethanamine;2-hydroxybenzoic acid |
InChI | InChI=1S/C17H21NO.C7H6O3/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;8-6-4-2-1-3-5(6)7(9)10/h3-12,17H,13-14H2,1-2H3;1-4,8H,(H,9,10) |
InChIKey | RTSZUSOHOIFYSY-UHFFFAOYSA-N |
SMILES | CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.C1=CC=C(C(=C1)C(=O)O)O |